The whole-genome landscape of medulloblastoma subtypes
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitating effects on the developing child, and highlight the need for molecularly targeted treatments with reduced toxicity. Previous studies have been unable to identify the full spectrum of driver genes and molecular processes that operate in medulloblastoma subgroups. Here we analyse the somatic landscape across 491 sequenced medulloblastoma samples and the molecular heterogeneity among 1,256 epigenetically analysed cases, and identify subgroup-specific driver alterations that include previously undiscovered actionable targets. Driver mutations were confidently assigned to most patients belonging to Group 3 and Group 4 medulloblastoma subgroups, greatly enhancing previous knowledge. New molecular subtypes were differentially enriched for specific driver events, including hotspot in-frame insertions that target KBTBD4 and ‘enhancer hijacking’ events that activate PRDM6. Thus, the application of integrative genomics to an extensive cohort of clinical samples derived from a single childhood cancer entity revealed a series of cancer genes and biologically relevant subtype diversity that represent attractive therapeutic targets for the treatment of patients with medulloblastoma. Genomic analysis of 491 medulloblastoma samples, including methylation profiling of 1,256 cases, effectively assigns candidate drivers to most tumours across all molecular subgroups. Medulloblastomas are highly malignant brain tumours that develop during childhood. Paul Northcott and colleagues analysed the whole-genome sequences of 491 medulloblastomas in order to characterize the genomic landscape across tumours and identify new drivers and mutational signatures. Their integrative genomic analyses, including methylation profiling of 1,256 medulloblastomas, identifies subgroup-specific driver mutations and suggests additional tumour subtypes. The authors assign driver mutations to a high proportion of the less well characterized Group 3 and Group 4, which together contribute to more than 60% of all medulloblastomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The overlap observed between the G3 and G4 tumors with respect to MYC amplification supports the working hypothesis that these medulloblastomas are not easily separable in part because they originate from a shared cerebellar progenitor cell pool, with each group arising from arrest at different points along a developmental stage continuum (8, 23).”
From The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from Patients (2025) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Methylation array–based classification studies have categorized the G3/G4-2, G3/G4-3, and G3/G4-4 molecular subgroups as G3; the G3/G4-1, G3/G4-5, and G3/G4-6 subgroups as a mix of G3 and G4; and the G3/G4-7 and G3/G4-8 subgroups as primarily G4 (8).”
From The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from Patients (2025) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 2×
“T 0) 42 .”
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657 · cited 1×
“The relatively recent recognition of consensus MB subgroups has rapidly changed the way MB is studied in the research setting and how it is diagnosed and treated in the clinic 39 .”
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621 · cited 1×
“The functional effect of the mutations was annotated using Annovar 43 and the variants were assessed for their confidence and split into somatic and non-somatic calls.”
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · cited 1×
“…previously detected in MB 16 and has been linked with underlying BRCA1 and BRCA2 mutations in breast, aggressive prostate, and pancreatic cancers 16,17 , was unexpectedly observed in most of the patients with Group 3 and Group 4 MB, and a subset of patients with SHH MB. Additional…”
Self-citationComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Cited by
Items 901–998 of 998
Kats, I., Schreiber, H. S., Simovic-Lorenz, M., Sant, P., Mallm, J., Li, A., Velmurugan, P., Weil, S., Devens, F., Sill, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.03.530989 · Cited by 1
“Despite recent efforts [5-12], the molecular basis of the aggressiveness of LFS medulloblastoma remains largely unknown.”
BackgroundSelf-citationAdvances of Immunotherapies for Pediatric Brain TumorsPreprint
Li, J., Zhao, X., & Pei, Y. (2024) · Preprints.org · doi:10.20944/preprints202401.0882.v1 · Cited by 1
Hruby, L., Scharov, K., Delaidelli, A., Picard, D. J., Dunham, C. P., Lewandowska, O., Reiff, T., Larcher, M., Pouponnot, C., Sorensen, P. H. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.06.583558 · Cited by 1
Essuman, K., Yang, Y., Goodman, E., Cambridge, C. N., Cai, C., An, Z., Mao, S., Manam, M. D., Finander, B., Khoshkhoo, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.27.708647 · Cited by 5
Editorial: Hot Topics in Neuro-Oncology
Soffietti, R. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000618
Klinischer Nutzen der molekularen Diagnostik pädiatrischer Hirntumore
Milde, T., & Witt, O. (2018) · Klinische Pädiatrie · doi:10.1055/a-0750-8353
Self-citationConcepts of Personalized Medicine in Neuro-oncology
Weller, M., Westphal, M., & Reardon, D. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_5
Ah-Pine, F., & Rousseau, A. (2019) · EMC - Neurologia · doi:10.1016/s1634-7072(19)42495-1
The Topology of Mutated Driver PathwaysPreprint
Dridi, R., Alghassi, H., Obeidat, M., & Tayur, S. R. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1912.00108
“Both algorithms are in widespread use in whole-genome analysis–for instance, in [16, 17, 4, 20].”
Top ten discoveries of the year: Neurooncology
Wesseling, P. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-2671
Comprehensive Molecular Profiling of Cancer Progression and Rare Cancers
de la Vega, L. L. (2019) · Deep Blue (University of Michigan) · Cited by 1
Guo, L., Cornick, K., Xu, V. E., Hao, T., Ilagan, M. X. G., Buchser, W., Rubin, J. B., & Li, F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.19.122515
Medulloblastoma: From Origin to Treatment
Lu, Y. (2020) · Novel Approaches in Cancer Study · doi:10.31031/nacs.2020.04.000599
Next-Generation Profiling of Medulloblastoma: Old Drugs Are an Elegant Weapon in a Civilized Age
Nör, C., & Ramaswamy, V. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3708
“However, targeted therapies have remained elusive partially due to the paucity of actionable mutations, particularly in the higher risk group (5).”
BackgroundSelf-citationBočkaj, I. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.156023051
Biological and molecular markers in childhood malignancies
Raskin, S., & Angiolillo, A. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00020-2
Milan, M. B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-27052020-081149
Rivero-Hinojosa, S., Grant, M., Panigrahi, A. K., Zhang, H., Caisová, V., Bollard, C. M., & Rood, B. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.13.456263 · Cited by 1
A Novel Oncogenic Function of PRC2 Heterogeneity in MedulloblastomaPreprint
Yi, J., Shi, X., Zhan, X., Lu, R. Q., Xuan, Z., & Wu, J. I. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.02.470979
Ayuda china para la modernización del ferrocarril cubano
Maestro, Á. (2006) · Vía libre
Intercambio de información entre Administraciones Públicas y derechos de defensa
Reyna, E. L. (1994) · Civitas. Revista española de derecho administrativo/Civitas. Revista española de derecho administrativo · Cited by 1
Dynamic interplay between structural variations and 3D chromosome organization in pancreatic cancerPreprint
Du, Y., Gu, Z., Li, Z., Yuan, Z., Zhao, Y., Zheng, X., Bo, X., Chen, H., & Wang, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.15.471847
Self-citationBryant, J.-P., & Niazi, T. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-80522-7_18
Duke, E. S., Wells, E. M., Vézina, G., & Packer, R. J. (2021) · Springer Publishing Company eBooks · doi:10.1891/9780826143990.0009
Medulloblastoma: Immune microenvironment and targeted nano-therapy
Wang, Q., & Liu, J. (2022) · OpenNano · doi:10.1016/j.onano.2022.100035
Gene Musashi-1 em meduloblastoma de grupo 3 e 4
Chagas, P. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-11042022-141239
Paediatric CNS tumoursPreprint
Nair, R. P., Nayal, B., Beedkar, S., & Menon, G. R. (2022) · Research Square · doi:10.21203/rs.3.rs-1560248/v1
Molecular profile reveals immune-associated markers of medulloblastoma for different subtypesPreprint
li, S., Kang, Z., Chen, J., Wang, C., Cai, Z., Pan, L., Chen, F., & Li, W. (2021) · Research Square · doi:10.21203/rs.3.rs-816357/v2
D’Angiolella, V. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736250307.793563274
Faculty Opinions recommendation of The chromatin accessibility landscape of primary human cancers.
Khurana, E. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734290128.793558601
Li, F., Yuan, H., Chen, C., Pan, J., Xu, X., Lin, C.-Y., Chen, W., Li, Y., Lin, J., & Li, J. (2021) · Research Square · doi:10.21203/rs.3.rs-328561/v1
Niehusmann, P., Stensvold, E., Leske, H., Pietsch, T., Goschzik, T., Gielen, G. H., Due‐Tønnessen, B. J., Frič, R., Nilssen, Y., & Brandal, P. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29736
“7,8 There is an increasing amount of data confirming the prognostic significance of molecular characteristics in MB.”
BackgroundChagas, P. S., Veronez, L. C., de Sousa, G. R., Cruzeiro, G. A. V., Corrêa, C. A. P., Saggioro, F. P., Queiróz, R. G. D. P., Marie, S. K. N., Brandalise, S. R., Cardinalli, I. A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1800310/v1
Prediction of the 3D cancer genome from genomic rearrangements using InfoHiCPreprint
Lee, Y., Park, S., & Lee, H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.02.502462
Zhang, Z., Wu, Y., Li, L., Zhai, X., & Liang, P. (2022) · Research Square · doi:10.21203/rs.3.rs-2053751/v1
Hatim, G., Chekrine, T., Houjami, M., Karami, S., Bouchbika, Z., Benchakroun, N., Jouhadi, H., Tawfiq, N., Hilmani, S., Karkouri, M., et al. (2022) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2022.4.5.1418
“Radiotherapy (RT) should be performed within 30 days after surgery [18].”
BackgroundMaureille, A., & Sunyach, M. (2022) · EMC - Neurologia · doi:10.1016/s1634-7072(22)46726-2
Revana: a comprehensive tool for regulatory variant analysis and visualization of cancer genomes
Ulrich, E., Pfister, S. M., & Jäger, N. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac831
Self-citationEditorial: Developmental therapeutics in pediatric neuro-oncology
Makimoto, A., Erdreich‐Epstein, A., & Muragaki, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1134168
“Based on molecular profiling the early classification designated four molecularly-distinct MB subgroups: Wingless (WNT), Sonic Hedgehog (SHH), Group 3, and Group 4 (3, 4).”
BackgroundEchavidre, W., Durivault, J., Gotorbe, C., Blanchard, T., Pagnuzzi‐Boncompagni, M., Vial, V., Raes, F., Broisat, A., Villeneuve, R., Amblard, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.08.531652
“INTRODUCTION Brain tumors are the second most common childhood tumors after hematologic cancers (1).”
BackgroundAssociation of an eight-gene signature prognosis model with tumor immunity in medulloblastomaPreprint
Jiang, T., Han, D., Jia, Z., Zou, W., Liu, R., Hu, Y., Qiu, X., Li, C., Liu, H., & Li, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2723037/v1
Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Borgenvik, A., Holmberg, K. O., Bolin, S., Zhao, M., Savov, V., Rosén, G., Hutter, S., Garancher, A., Rahmanto, A. S., Bergström, T., et al. (2023) · doi:10.1158/0008-5472.c.6514337.v1
Self-citationMo, J., Liu, F., Sun, X., Huang, H., Tan, K., Zhao, X., Li, R., Jiang, W., Sui, Y., Chen, X., et al. (2023) · doi:10.1158/0008-5472.c.6513424.v1
Tao, R., Murad, N., Xu, Z., Zhang, P., Okonechnikov, K., Kool, M., Rivero-Hinojosa, S., Lazarski, C. A., Zheng, P., Liu, Y., et al. (2023) · doi:10.1158/0008-5472.22423277
Self-citationTao, R., Murad, N., Xu, Z., Zhang, P., Okonechnikov, K., Kool, M., Rivero-Hinojosa, S., Lazarski, C. A., Zheng, P., Liu, Y., et al. (2023) · doi:10.1158/0008-5472.22423277.v1
Self-citationDelaidelli, A., Dunham, C. P., Santi, M., Negri, G. L., Triscott, J., Zheludkova, O., Голанов, А. В., Ryzhova, M. V., Okonechnikov, K., Schrimpf, D., et al. (2023) · doi:10.1158/1078-0432.c.6531056
Self-citationDelaidelli, A., Dunham, C. P., Santi, M., Negri, G. L., Triscott, J., Zheludkova, O., Голанов, А. В., Ryzhova, M. V., Okonechnikov, K., Schrimpf, D., et al. (2023) · doi:10.1158/1078-0432.c.6531056.v1
Self-citationXue, Y., Fu, Y., Zhao, F., Gui, G., Li, Y., Rivero-Hinojosa, S., Liu, G., Li, Y.-Q., Xia, S., Eberhart, C. G., et al. (2023) · doi:10.1158/1535-7163.22522281
Xue, Y., Fu, Y., Zhao, F., Gui, G., Li, Y., Rivero-Hinojosa, S., Liu, G., Li, Y., Xia, S., Eberhart, C. G., et al. (2023) · doi:10.1158/1535-7163.c.6543321
Hirsch, T. Z., Pilet, J., Morcrette, G., Roehrig, A., Monteiro, B. J. E., Molina, L., Bayard, Q., Trépo, E., Meunier, L., Caruso, S., et al. (2023) · doi:10.1158/2159-8290.c.6549043.v1
Chen, Z., Zhang, X., Liu, G., Peng, P., He, Y., Wang, J., Dong, M., Guo, Z., Wan, F., Zeng, K., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1148848 · Cited by 1
“Trimmomatic 0.33 was used to trim and filter the raw data (stored as FastQ format) using the following parameters: (1) ILLUMINACLIP: TruSeq3-PE2.fa:3:30:10:8:true; (2) LEADING:5; (3) TRAILING:5; (4) AVGQUAL:20; and (5) MINLEN:36 (24).”
InfluentialIntegrated RNA-Seq Analysis for Identification of Differentially Expressed Gene in Medullo-Blastoma
Aizaz, M. (2023) · Significances of Bioengineering & Biosciences · doi:10.31031/sbb.2023.06.000631
Kulaç, İ., & Pekmezci, M. (2023) · doi:10.1093/med/9780197573778.003.0001
Perek‐Polnik, M., Cochrane, A. M., Wang, J., Chojnacka, M., Drogosiewicz, M., Filipek, I., Święszkowska, E., Tarasińska, M., Grajkowska, W., Trubicka, J., et al. (2023) · Children · doi:10.3390/children10081387 · Cited by 3
“The tumor is most commonly classified into four molecular subtypes: wingless (WNT), sonic hedgehog (SHH), group 3, and group 4 [3,4].”
BackgroundSingh, S. V., Bharambe, H. S., Masurkar, S. A., Bapat, P., Gadewal, N. S., & Shirsat, N. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.15.553361
“These domains contain the ATPase and RNA helicase motifs required for the ATP hydrolysis and RNA substrate binding and unwinding (11,12,14).”
BackgroundThe Tale of Two Hedgehogs: Central Nervous System Embryonal Tumor Diagnosis in 3 Acts
Drake, R. F., & Ames, H. M. (2020) · AJSP Review and Reports · doi:10.1097/pcr.0000000000000372
“Next-generation sequencing has introduced away to profile a large number of somatic driver mutations simultaneously.(11) The signaling pathways for which subgroups of medulloblastoma are named reflect the pathways impacted by the most common somatic mutations.”
BackgroundWNT-Activated Medulloblastoma in A 6-Year-Old Boy
Prasetyo, P. D., & Wahjoepramono, E. J. (2023) · Medicinus · doi:10.19166/med.v11i2.7530
SJPedPanel: A pan-cancer gene panel for childhood malignanciesPreprint
Kolekar, P. S., Balagopal, V., Dong, L., Liu, Y., Foy, S. G., Tran, Q., Mulder, H. L., Huskey, A. L. W., Plyler, E. M., Liang, Z., et al. (2023) · medRxiv · doi:10.1101/2023.11.27.23299068
Self-citationAssociation of an eight-gene signature prognosis model with tumor immunity in medulloblastomaPreprint
Han, D., Jia, Z., Zou, W., Liu, R., Hu, Y., Qiu, X., Li, C., Liu, H., Li, J., & Jiang, T. (2024) · Research Square · doi:10.21203/rs.3.rs-2723037/v2
Dinikina, Y. V., Zheludkova, O., Belogurova, M. B., Spelnikov, D., Osipov, N. N., & Nikitina, I. L. (2024) · Journal of Modern Oncology · doi:10.26442/18151434.2023.4.202521
Han, D., Jia, Z., Wang, Z., Chen, X., Yang, Z., Zou, W., Liu, R., Jiang, Y., Jin, X., Hu, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-2723037/v3
Additional file 9 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298923
Self-citationAdditional file 16 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516564
Li, M., Han, Y., Wang, C., Kang, W., Jiang, W., Zhang, L., & Tang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21384550
Additional file 12 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516552
Additional file 5 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516585
Additional file 8 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298920
Self-citationLi, M., Han, Y., Wang, C., Kang, W., Jiang, W., Zhang, L., & Tang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21384565
Additional file 3 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516579
Li, M., Han, Y., Wang, C., Kang, W., Jiang, W., Zhang, L., & Tang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21384562
Additional file 6 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298914
Self-citationAdditional file 2 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298902
Self-citationAdditional file 4 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516582
Li, M., Han, Y., Wang, C., Kang, W., Jiang, W., Zhang, L., & Tang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21384559
Additional file 7 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298917
Self-citationAdditional file 8 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516594
Additional file 9 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516597
Sanjaya, P., Maljanen, K., Katainen, R., Waszak, S. M., Aaltonen, L. A., Stegle, O., Korbel, J. O., & Pitkänen, E. (2023) · Figshare · doi:10.6084/m9.figshare.23647579
Self-citationLi, M., Han, Y., Wang, C., Kang, W., Jiang, W., Zhang, L., & Tang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21384553
Additional file 7 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516591
Additional file 4 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298908
Self-citationAdditional file 10 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516546
Additional file 11 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516549
Additional file 14 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516558
Additional file 3 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298905
Self-citationAdditional file 5 of Group-specific cellular metabolism in Medulloblastoma
Funke, V. L. E., Walter, C., Melcher, V., Wei, L., Sandmann, S., Hotfilder, M., Varghese, J., Jäger, N., Kool, M., Jones, D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23298911
Self-citationAdditional file 13 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516555
Additional file 2 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516576
Ni, L., Liu, Y., Ma, X., Liu, T., Yang, X., Wang, Z., Liang, Q., Liu, S., Zhang, M., Wang, Z., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22608293
Self-citationAdditional file 1 of Novel PHOX2B germline mutation in childhood medulloblastoma: a case report
Ke, C., Shi, X., Chen, A. M., Li, C., Jiang, B., Huang, K., Zheng, Z., Liu, Y., Chen, Z., Luo, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13612674
Self-citationLi, M., Han, Y., Wang, C., Kang, W., Jiang, W., Zhang, L., & Tang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21384556
Additional file 2 of Clinical and mutational profiles of adult medulloblastoma groups
Wong, G. C.-H., Li, K. K., Wang, W.-W., Liu, A. P. Y., Huang, Q. J., Chan, A. K., Poon, M. F., Chung, N. Y., Wong, Q. H., Chen, H., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13219304
Additional file 15 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516561
Additional file 6 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516588
Additional file 17 of Ten-eleven translocation protein 1 modulates medulloblastoma progression
Kim, H., Kang, Y., Li, Y., Chen, L., Lin, L., Johnson, N. D., Zhu, D., Robinson, M. H., McSwain, L., Barwick, B. G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516567
Pediatric Infratentorial Tumors’ Treatment in the Molecular Era
da Costa, M. D. S., Soares, C. T., Betta, V. H. C., da Silva, N. S., Cappellano, A. M., & Cavalheiro, S. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_263
Collins, R. R. J., Gee, R. R. F., Sanchez, M. C. H., Tozandehjani, S., Bayat, T., Breznik, B., Lee, A. K., Peters, S., Connelly, J. P., Pruett‐Miller, S. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.14.594201
Metadata
- Authors
- Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., Warnatz, H.-J., Sidiropoulos, N., Phillips, A. H., Schumacher, S., Kleinheinz, K., Waszak, S. M., Erkek, S., Jones, D. T. W., Worst, B. C., Kool, M., Zapatka, M., Jäger, N., Chavez, L., Hutter, B., Bieg, M., Paramasivam, N., Heinold, M., Gu, Z., Ishaque, N., Jäger-Schmidt, C., Imbusch, C. D., Jugold, A., Hübschmann, D., Risch, T., Amstislavskiy, V., Gonzalez, F. G. R., Weber, U. D., Wolf, S., Robinson, G. W., Zhou, X., Wu, G., Finkelstein, D., Liu, Y., Cavalli, F. M. G., Luu, B., Ramaswamy, V., Wu, X., Koster, J., Ryzhova, M., Cho, Y.-J., Pomeroy, S. L., Herold-Mende, C., Schuhmann, M., Ebinger, M., Liau, L. M., Mora, J., McLendon, R. E., Jabado, N., Kumabe, T., Chuah, E., Ma, Y., Moore, R. A., Mungall, A. J., Mungall, K. L., Thiessen, N., Tse, K., Wong, T., Jones, S. J. M., Witt, O., Milde, T., Von Deimling, A., Capper, D., Korshunov, A., Yaspo, M.-L., Kriwacki, R., Gajjar, A., Zhang, J., Beroukhim, R., Fraenkel, E., Korbel, J. O., Brors, B., Schlesner, M., Eils, R., Marra, M. A., Pfister, S. M., Taylor, M. D., & Lichter, P.
- Affiliations
- St. Jude Children's Research Hospital (US)
- German Cancer Research Center (DE)
- Hospital for Sick Children (CA)
- University of Copenhagen (DK)
- Massachusetts Institute of Technology (US)
- European Molecular Biology Laboratory (DE)
- Max Planck Institute for Molecular Genetics (DE)
- Broad Institute (US)
- Burdenko Neurosurgery Institute (RU)
- Oregon Health & Science University (US)
- Boston Children's Hospital (US)
- Universitätsklinikum Tübingen (DE)
- University Children's Hospital Tübingen (DE)
- University of California, Los Angeles (US)
- Hospital Sant Joan de Déu Barcelona (ES)
- Duke University (US)
- McGill University (CA)
- Kitasato University Hospital (JP)
- BC Cancer Agency (CA)
- University Hospital Heidelberg (DE)
- Corresponding author
- Pfister, Stefan M.
- Taylor, Michael D.
- Lichter, Peter
- ORCID
- Northcott, Paul A.
- Buchhalter, Ivo
- Morrissy, A. Sorana
- Hovestadt, Volker
- Weischenfeldt, Joachim
- Zichner, Thomas
- Rudneva, Vasilisa A.
- Warnatz, Hans-Jörg
- Sidiropoulos, Nikos
- Phillips, Aaron H.
- Schumacher, Steven
- Kleinheinz, Kortine
- Waszak, Sebastian M.
- Erkek, Serap
- Jones, David T. W.
- Kool, Marcel
- Zapatka, Marc
- Jäger, Natalie
- Hutter, Barbara
- Bieg, Matthias
- Paramasivam, Nagarajan
- Gu, Zuguang
- Ishaque, Naveed
- Imbusch, Charles D.
- Hübschmann, Daniel
- Amstislavskiy, Vyacheslav
- Robinson, Giles W.
- Zhou, Xin
- Wu, Gang
- Finkelstein, David
- Liu, Yanling
- Cavalli, Florence M. G.
- Ramaswamy, Vijay
- Wu, Xiaochong
- Ryzhova, Marina
- Cho, Yoon-Jae
- Pomeroy, Scott L.
- Schuhmann, Martin
- Ebinger, Martin
- Liau, Linda M.
- Mora, Jaume
- McLendon, Roger E.
- Jabado, Nada
- Kumabe, Toshihiro
- Moore, Richard A.
- Mungall, Andrew J.
- Wong, Tina
- Jones, Steven J. M.
- Witt, Olaf
- Milde, Till
- Capper, David
- Korshunov, Andrey
- Yaspo, Marie-Laure
- Kriwacki, Richard
- Gajjar, Amar
- Zhang, Jinghui
- Beroukhim, Rameen
- Fraenkel, Ernest
- Korbel, Jan O.
- Brors, Benedikt
- Schlesner, Matthias
- Eils, Roland
- Marra, Marco A.
- Pfister, Stefan M.
- Taylor, Michael D.
- Lichter, Peter
- Venue
- Nature
- Published
- 2017-07
- Volume
- 547
- Issue
- 7663
- Pages
- 311-317
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5905700
- OpenAlex
- W2737542366
- Cited by
- 1,112
- References
- 66
- Citations by year
- 2026: 63 · 2025: 132 · 2024: 125 · 2023: 154 · 2022: 142 · 2021: 148 · 2020: 120 · 2019: 120 · 2018: 94 · 2017: 12
- FWCI
- 54.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 19 d)
- Locations
- Nature (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Max Planck Digital Library (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- MPG.PuRe (Max Planck Society) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Funders
- Alexander and Margaret Stewart Trust
- Pediatric Brain Tumor Foundation (R01CA159859)
- Deutsches Krebsforschungszentrum
- Genome Canada (R01CA159859)
- Children's Hospital Foundation
- Ontario Institute for Cancer Research
- American Lebanese Syrian Associated Charities
- Government of Ontario
- Genome British Columbia (R01CA159859)
- Canada Research Chairs
- Brain Tumour Charity (GN-000356)
- Bundesministerium für Bildung und Forschung (01KU1505E, 01KU1201A, 01KU1505A)
- Terry Fox Research Institute (R01CA159859)
- Deutsche Krebshilfe (109252)
- Hospital for Sick Children
- Stichting Kinderen Kankervrij
- BC Cancer Foundation (FDN-143288)
- Brain Tumour Research
- National Institutes of Health
- Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft
- Garron Family Cancer Centre
- National Cancer Institute (R01CA148699, R01CA109467, R01CA159859)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- medulloblastoma, molecular subtypes, driver mutations, somatic mutations, mutational signatures, enhancer hijacking, in-frame insertion, DNA methylation, Group 3 medulloblastoma, Group 4 medulloblastoma, therapeutic target, childhood brain tumours, integrative genomics
- MeSH terms
- Whole Genome Sequencing, Carrier Proteins, DNA Mutational Analysis, Epistasis, Genetic, Humans, Medulloblastoma, Muscle Proteins, Mutation, Oncogenes, Transcription Factors, Cohort Studies, Genome, Human, DNA Methylation, Genomics, Wnt Proteins, Molecular Targeted Therapy, Carcinogenesis, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.